JP2006500315A
(ja)
*
|
2002-01-11 |
2006-01-05 |
アボット・ラボラトリーズ |
糖尿病状態に用いるヒスタミン−3受容体リガンド
|
WO2004063715A2
(en)
*
|
2003-01-10 |
2004-07-29 |
The Trustees Of Columbia University In The City Of New York |
Methods of using crystal structure of carboxyltransferase domain of acetyl-coa carboxylase, modulators thereof, and computer methods
|
CA2515368A1
(en)
|
2003-02-13 |
2004-08-26 |
Luciano Rossetti |
Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
|
EP1608317B1
(de)
|
2003-03-25 |
2012-09-26 |
Takeda Pharmaceutical Company Limited |
Dipeptidylpeptidase-hemmer
|
US7470700B2
(en)
|
2003-08-13 |
2008-12-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
JP2007505121A
(ja)
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
BRPI0416287A
(pt)
*
|
2003-11-07 |
2007-01-23 |
Hoffmann La Roche |
compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
|
GB0326029D0
(en)
*
|
2003-11-07 |
2003-12-10 |
Astrazeneca Ab |
Chemical compounds
|
US7732446B1
(en)
|
2004-03-11 |
2010-06-08 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
AU2004318013B8
(en)
|
2004-03-15 |
2011-10-06 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2005113069A2
(en)
*
|
2004-05-14 |
2005-12-01 |
Research Development Foundation |
Use of circumin and analogues as inhibitors of acc2
|
JP2008501714A
(ja)
|
2004-06-04 |
2008-01-24 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
DE602005025755D1
(de)
|
2004-06-04 |
2011-02-17 |
Teva Pharma |
Irbesartan enthaltende pharmazeutische zusammensetzung
|
US7150969B2
(en)
*
|
2004-06-04 |
2006-12-19 |
Rosetta Inpharmatics Llc |
Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
|
MXPA06014574A
(es)
*
|
2004-06-24 |
2007-03-12 |
Incyte Corp |
Piperidinas n-sustituidas y su uso como farmaceuticos.
|
US7618980B2
(en)
*
|
2004-07-14 |
2009-11-17 |
Bristol-Myers Squibb Company |
Pyrrolo(oxo)quinolines as 5HT ligands
|
US7572805B2
(en)
|
2004-07-14 |
2009-08-11 |
Bristol-Myers Squibb Company |
Pyrrolo(oxo)isoquinolines as 5HT ligands
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
JP2008524331A
(ja)
|
2004-12-21 |
2008-07-10 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼ阻害剤
|
MX2007007428A
(es)
|
2004-12-24 |
2007-07-16 |
Astrazeneca Ab |
Compuestos heterociclicos, antagonistas de ccr2b.
|
WO2006086464A2
(en)
|
2005-02-10 |
2006-08-17 |
Bristol-Myers Squibb Company |
Dihydroquinazolinones as 5ht modulators
|
ATE509023T1
(de)
*
|
2005-07-19 |
2011-05-15 |
Merck Sharp & Dohme |
Spirochromanon-derivate als acetyl-koenzym-a- carboxylase-hemmer
|
JPWO2007013691A1
(ja)
*
|
2005-07-29 |
2009-02-12 |
武田薬品工業株式会社 |
スピロ環化合物
|
US7795436B2
(en)
|
2005-08-24 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
|
CA2622472C
(en)
|
2005-09-14 |
2013-11-19 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetes
|
CN101360723A
(zh)
|
2005-09-16 |
2009-02-04 |
武田药品工业株式会社 |
制备嘧啶二酮衍生物的方法
|
US20100016289A1
(en)
*
|
2005-11-01 |
2010-01-21 |
Kevin Sprott |
Compounds Useful as Antagonists of CCR2
|
US8067415B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
WO2007053498A1
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
WO2007095602A2
(en)
*
|
2006-02-15 |
2007-08-23 |
Abbott Laboratories |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
CN101384568B
(zh)
*
|
2006-02-15 |
2012-12-12 |
雅培制药有限公司 |
乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EP2009011A1
(de)
|
2006-04-14 |
2008-12-31 |
Takeda Pharmaceutical Company Limited |
Stickstoffhaltige heterocyclische verbindung
|
BRPI0715160A2
(pt)
|
2006-08-08 |
2013-06-11 |
Sanofi Aventis |
imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
|
AU2007296556B2
(en)
*
|
2006-09-13 |
2013-09-19 |
Takeda Pharmaceutical Company Limited |
Use of 2-6- (3-Amino-piperidin-1-yl) -3-methyl-2, 4-dioxo-3, 4-dihydro-2H-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
PE20081559A1
(es)
|
2007-01-12 |
2008-11-20 |
Merck & Co Inc |
DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
|
WO2008088692A2
(en)
|
2007-01-12 |
2008-07-24 |
Merck & Co., Inc. |
Spirochromanon derivatives
|
JPWO2008090944A1
(ja)
|
2007-01-25 |
2010-05-20 |
武田薬品工業株式会社 |
スピロ環化合物
|
WO2008103382A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Sergey Kozmin |
Method for assembling high-purity chemical libraries, compounds suppressing acetyl coenzyme a carboxylase activities discovered by same
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
JP2010527360A
(ja)
*
|
2007-05-14 |
2010-08-12 |
ニューエラ・ファーマシューティカルズ・インコーポレーテッド |
神経細胞の代謝低下の処置のためのアセチル−coaカルボキシラーゼの阻害剤
|
CN101820757A
(zh)
|
2007-06-01 |
2010-09-01 |
普林斯顿大学托管委员会 |
通过调节宿主细胞代谢途径治疗病毒感染
|
DK2170930T3
(da)
|
2007-06-04 |
2012-11-05 |
Synergy Pharmaceuticals Inc |
Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7981904B2
(en)
|
2008-03-20 |
2011-07-19 |
Takeda Pharmaceutical Company Limited |
Acetyl CoA carboxylase inhibitors
|
WO2009144554A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer, Inc. |
Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
US8524730B2
(en)
|
2008-07-04 |
2013-09-03 |
Msd K.K. |
Spirochromanone carboxylic acids
|
TW201014822A
(en)
|
2008-07-09 |
2010-04-16 |
Sanofi Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
US20100113473A1
(en)
|
2008-10-30 |
2010-05-06 |
Player Mark R |
Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
CN102482312A
(zh)
|
2009-08-26 |
2012-05-30 |
赛诺菲 |
新颖的杂芳族氟代糖苷结晶水合物、含有这些化合物的药物和它们的用途
|
ES2444543T3
(es)
|
2009-11-10 |
2014-02-25 |
Pfizer Inc |
Inhibidores de la N1-pirazoloespirocetona acetil-CoA carboxilasa
|
RU2524341C2
(ru)
|
2010-03-19 |
2014-07-27 |
Пфайзер Инк. |
Производные 2,3-дигидро-1н-инден-1-ил-2,7-диазаспиро[3.5]нонана и их применение в качестве антагонистов или обратных агонистов грелинового рецептора
|
TW201206911A
(en)
*
|
2010-04-27 |
2012-02-16 |
Takeda Pharmaceutical |
Bicyclic compound
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
PT2621493T
(pt)
|
2010-09-30 |
2016-11-14 |
Pfizer |
Inibidores de n1-pirazolospirocetona acetil-coa carboxilase
|
CN103189377B
(zh)
|
2010-10-29 |
2015-02-25 |
辉瑞大药厂 |
N1/n2-内酰胺乙酰辅酶a羧化酶抑制剂
|
WO2012120050A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
WO2012120051A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683703B1
(de)
|
2011-03-08 |
2015-05-27 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
PT2699576E
(pt)
|
2011-04-22 |
2016-03-09 |
Pfizer |
Derivados de pirazoloespirocetona para utilização como inibidores de acetil-coa carboxilase
|
WO2013011402A1
(en)
|
2011-07-15 |
2013-01-24 |
Pfizer Inc. |
Gpr 119 modulators
|
MX2014000855A
(es)
|
2011-07-22 |
2014-04-30 |
Pfizer |
Moduladores receptores de glucagon de quinolinilo.
|
WO2013030713A1
(en)
|
2011-08-31 |
2013-03-07 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds
|
EP2567959B1
(de)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
|
UA123760C2
(uk)
|
2011-11-11 |
2021-06-02 |
Гіліад Аполло, Ллс |
Сполука (варіанти) та композиція, що містить сполуку
|
WO2013068875A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
2-thiopyrimidinones
|
US8530460B2
(en)
*
|
2011-12-19 |
2013-09-10 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives
|
US8530461B2
(en)
|
2011-12-29 |
2013-09-10 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives
|
US8623860B2
(en)
|
2011-12-30 |
2014-01-07 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives, pharmaceutical compositions and uses thereof
|
AU2013245353A1
(en)
|
2012-04-06 |
2014-09-25 |
Pfizer Inc. |
Diacylglycerol acyltransferase 2 inhibitors
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
CA2872154C
(en)
|
2012-05-04 |
2016-08-23 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin-2-amine compounds as inhibitors of app, bace1 and bace2
|
CA2882389A1
(en)
|
2012-09-20 |
2014-03-27 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
JP2016502978A
(ja)
|
2012-12-11 |
2016-02-01 |
ファイザー・インク |
BACE1の阻害剤としてのヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物
|
JP6162820B2
(ja)
|
2012-12-19 |
2017-07-12 |
ファイザー・インク |
炭素環式および複素環式置換ヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物
|
WO2014125394A1
(en)
|
2013-02-13 |
2014-08-21 |
Pfizer Inc. |
HETEROARYL-SUBSTITUTED HEXAHYDROPYRANO [3,4-d][1,3] THIAZIN-2-AMINE COMPOUNDS
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
EP2976333B1
(de)
*
|
2013-03-18 |
2018-08-08 |
Genoscience Pharma SAS |
Chinolinderivate als neuartige antikrebsmittel
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
KR20160042089A
(ko)
|
2013-09-12 |
2016-04-18 |
화이자 인코포레이티드 |
심상성 여드름 치료용 아세틸-CoA 카복실라아제 억제제의 용도
|
EP3055300B1
(de)
|
2013-10-09 |
2018-03-07 |
Pfizer Inc |
Antagonisten des prostaglandin-ep3-rezeptors
|
US9809569B2
(en)
|
2014-03-14 |
2017-11-07 |
Takeda Pharmaceutical Company Limited |
Process for producing heterocyclic compound
|
AU2015233094B2
(en)
|
2014-03-17 |
2017-04-27 |
Pfizer Inc. |
Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders
|
ES2910128T3
(es)
|
2014-04-04 |
2022-05-11 |
Pfizer |
Compuestos de heteroarilo o arilo fusionados con biciclo y su uso como inhibidores de IRAK4
|
MD20160105A2
(ro)
|
2014-04-10 |
2017-03-31 |
Pfizer Inc. |
2-Amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8H)-il-1,3-tiazol-4-il amide
|
WO2016092413A1
(en)
|
2014-12-10 |
2016-06-16 |
Pfizer Inc. |
Indole and indazole compounds that activate ampk
|
WO2016103097A1
(en)
|
2014-12-22 |
2016-06-30 |
Pfizer Inc. |
Antagonists of prostaglandin ep3 receptor
|
CR20170498A
(es)
|
2015-05-05 |
2018-01-26 |
Pfizer |
2-tiopirimidinonas
|
US10308615B2
(en)
|
2015-05-29 |
2019-06-04 |
Pfizer Inc. |
Heterocyclic compounds as inhibitors of Vanin-1 enzyme
|
CA2989456C
(en)
|
2015-06-17 |
2022-01-04 |
Pfizer Inc. |
Tricyclic compounds and their use as phosphodiesterase inhibitors
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
BR112018002071A2
(pt)
|
2015-08-13 |
2018-09-18 |
Pfizer |
compostos heteroarílicos ou arílicos fundidos bicíclicos
|
DK3341367T3
(da)
|
2015-08-27 |
2021-04-12 |
Pfizer |
Bicyklisk-fusionerede heteroaryl- eller arylforbindelser som irak4-modulatorer
|
WO2017037567A1
(en)
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
N−[2−(2−アミノ−6,6−二置換−4,4a,5,6−テトラヒドロピラノ[3,4−d][1,3]チアジン−8a(8H)−イル)−1,3−チアゾール−4−イル]アミド
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ[3,4−d][1,3]オキサジン誘導体、およびbace阻害剤としてのその使用
|
WO2017051294A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
|
AR106472A1
(es)
|
2015-10-26 |
2018-01-17 |
Gilead Apollo Llc |
Inhibidores de acc y usos de los mismos
|
KR20180082556A
(ko)
|
2015-11-25 |
2018-07-18 |
길리어드 아폴로, 엘엘씨 |
피라졸 acc 억제제 및 그의 용도
|
MX2018006288A
(es)
|
2015-11-25 |
2018-09-07 |
Gilead Apollo Llc |
Inhibidores de acc tipo ester y usos de los mismos.
|
CN108347939B
(zh)
|
2015-11-25 |
2021-09-28 |
吉利德阿波罗公司 |
含有2,4-二氧代-1,4-二氢噻吩并[2,3-d]嘧啶的衍生物的杀真菌组合物
|
JP2018536661A
(ja)
|
2015-11-25 |
2018-12-13 |
ギリアド アポロ, エルエルシー |
トリアゾールacc阻害剤およびその使用
|
LT3397631T
(lt)
|
2015-12-29 |
2021-06-10 |
Pfizer Inc. |
Pakeisti 3-azabiciklo[3.1.0]heksanai kaip ketoheksokinazės inhibitoriai
|
BR112018067408A2
(pt)
|
2016-03-02 |
2018-12-26 |
Gilead Apollo Llc |
formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas
|
EP3266454A1
(de)
*
|
2016-07-07 |
2018-01-10 |
Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften |
Acc-hemmer zur verwendung bei der behandlung von mycobakteriellen erkrankungen
|
EP3484876A1
(de)
|
2016-07-14 |
2019-05-22 |
Pfizer Inc |
Neuartige pyrimidincarboxamide als inhibitoren des vanin-1-enzyms
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
JP6906626B2
(ja)
|
2017-03-28 |
2021-07-21 |
ギリアード サイエンシーズ, インコーポレイテッド |
肝疾患を処置するための治療的組み合わせ
|
WO2019133445A1
(en)
|
2017-12-28 |
2019-07-04 |
Inception Ibd, Inc. |
Aminothiazoles as inhibitors of vanin-1
|
AU2019329884B2
(en)
|
2018-08-31 |
2022-01-27 |
Pfizer Inc. |
Combinations for treatment of NASH/NAFLD and related diseases
|
WO2020102575A1
(en)
|
2018-11-16 |
2020-05-22 |
Inception Ibd, Inc. |
Heterocyclic aminothiazoles and uses thereof
|
US20220387402A1
(en)
|
2019-05-20 |
2022-12-08 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
WO2023169456A1
(en)
|
2022-03-09 |
2023-09-14 |
Gasherbrum Bio , Inc. |
Heterocyclic glp-1 agonists
|
WO2023198140A1
(en)
|
2022-04-14 |
2023-10-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
WO2024125602A1
(en)
|
2022-12-15 |
2024-06-20 |
Gasherbrum Bio, Inc. |
Salts and solid forms of a compound having glp-1 agonist activity
|